2021
DOI: 10.1186/s12967-021-03016-9
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of microsomal prostaglandin E synthase-1 ameliorates acute lung injury in mice

Abstract: Background To examine the effects of BI 1029539 (GS-248), a novel selective human microsomal prostaglandin E synthase-1 (mPGES-1) inhibitor, in experimental models of acute lung injury (ALI) and sepsis in transgenic mice constitutively expressing the mPGES1 (Ptges) humanized allele. Methods Series 1: Lipopolysaccharide (LPS)-induced ALI. Mice were randomized to receive vehicle, BI 1029539, or celecoxib. Series 2: Cecal ligation and puncture-induced… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
11
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 13 publications
(12 citation statements)
references
References 43 publications
1
11
0
Order By: Relevance
“…BAL was collected from anesthetized mice through a 20-gage angiocath as previously described (Gurusamy et al 2021 ). Briefly, 4 ml of sterile PBS was instilled into the rat lung and lavaged three times.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…BAL was collected from anesthetized mice through a 20-gage angiocath as previously described (Gurusamy et al 2021 ). Briefly, 4 ml of sterile PBS was instilled into the rat lung and lavaged three times.…”
Section: Methodsmentioning
confidence: 99%
“…The lower lobes of the right lung were harvested in all animals to determine the edema index (wet/dry ratio) as previously described (Gurusamy et al 2021 ). In brief, The wet weight of the right lower lungs was measured at the time scarification.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Due to compound-specific liver toxicity this program was discontinued (Norman et al, 2018). In support, a phase I clinical study using the selective mPGES-1 inhibitor GS-248 (alternative name OX-MPI, BI 1029539) (Gurusamy et al, 2021;Soldner et al, 2019) at sub-nanomolar concentration demonstrated inhibition of LPS-induced PGE 2 biosynthesis in ex vivo blood from healthy volunteers. In addition, a significant and durable inhibition of urinary PGE 2 -M was observed, accompanied with an increase of urinary PGI 2 -M (Edenius et al, 2020).…”
Section: Introductionmentioning
confidence: 99%
“…A recent approach for finding safer anti‐inflammatory agents involves inhibiting the synthesis of PGE2. PGE2 is a principle inflammatory mediator biosynthesized through a series of reactions starting from arachidonic acid (AA) which is converted to prostaglandin H 2 (PGH 2 ) via a cyclooxygenase enzyme (COX), PGH 2 is subsequently converted to PGE2 via prostaglandin E synthases (PGES) (Gomez et al, 2013; Gurusamy et al, 2021; Meuillet & Meuillet, 2011). PGES involves three isoforms: two of them, namely, cytosolic PGES (cPGES) and microsomal (mPGES‐2) are constitutively expressed.…”
Section: Introductionmentioning
confidence: 99%